The Effectiveness of Mirena Intrauterine Device in the Treatment of Adenomyosis

Objective: To explore the efficacy of the Mirena intrauterine device (IUD) in the treatment of patients with adenomyosis. Methods: Forty patients with adenomyosis treated in our hospital from January 2021 to December 2024 were randomly divided into an observation group and a control group, with 20 cases in each group. The observation group received Mirena IUD treatment, while the control group received drug treatment. The treatment indicators were compared between the two groups. Results: The total effective rate in the observation group was higher than that in the control group (P < 0.05). After treatment, the levels of sex hormone indicators in the observation group were better than those in the control group (P < 0.05). Compared with the control group, the observation group had significant improvements in menstrual pain score, menstrual volume score, uterine volume, and endometrial thickness (P < 0.05). The incidence of adverse reactions in the observation group was significantly lower than that in the control group (P < 0.05). Conclusion: The treatment of adenomyosis patients with Mirena IUD is significantly effective, which can effectively improve menstrual volume and reduce the degree of menstrual pain. With fewer adverse reactions, the treatment is safer and feasible for promotion.